Wednesday, October 16
2.0 CME CREDITS
Hodgkin lymphoma has remained a mystery for generations, and pathologists have often struggled to distinguish it from non-Hodgkin lymphomas and other histopathologic imitators. Recent discoveries have greatly improved our understanding of this enigmatic disorder, suggesting that virtually all cases are derived from a unique type of germinal center B-cell that has undergone crippling mutations of its immunoglobulin gene expression apparatus. This course provides a historical perspective on Hodgkin lymphoma, and then describes the range of morphologic and immunophenotypic features that can be displayed in individual cases, including patterns of expression of novel transcription factors, emphasizing features that permit distinction from Hodgkin lymphoma from both malignant and benign pathologic mimickers.
You will learn to:
Patrick A. Treseler, MD, PhD, FCAP